A Johnson & Johnson scientist works in a laboratory during the development and testing of the Janssen COVID-19 vaccine in this undated photo. The U.S. Food and Drug Administration approved use of the company's one-shot vaccine Feb. 27, 2021. (CNS photo/Johnson & Johnson, Handout via Reuters) Editor's note: No resales. No archives.
Editorial: With vaccines, nuance gets lost in the headlines
The COVID-19 pandemic presents one of those complicated situations that requires a nuanced response.
